Acta Med. 2006, 49: 101-104
https://doi.org/10.14712/18059694.2017.119
Serum Adenosine Deaminase Activity in Monitoring Disease Activity and Response to Therapy in Severe Psoriasis
References
1. Clin Exp immunol 1976; 26:647–9.
A, Harkness RA. Adenosine deaminase activity in thymus and other human tissues.
2. Sarcoidosis 1993; 10:18–25.
C, Mabritto i, Ghio P, Solidoro P, Marchetti L, Pozzi E. Adenosine deaminase activity and fibronectin levels in bronchoalveolar lavage fluid in sarcoidosis and tuberculosis.
3. Br J Dermatol 1992; 126:1–9.
< BS, Fry L. The immunology of psoriasis. https://doi.org/10.1111/j.1365-2133.1992.tb08394.x>
4. Hum Hered 1977; 27:408–11.
< G, Beckman L, Cedergren B, Liden S. Red cell enzyme types in psoriasis. https://doi.org/10.1159/000152902>
5. Eur J Dermatol. 2000; 10:274–6.
G, Akan T, Ciliv G. Serum adenosine deaminase levels in patients with psoriasis: a prospective case-control study.
6. Giusti G, Galanti B. Colorimetric method. In: Methods of Enzymatic Analysis (Bergmeyer HU, ed.). Weinheim: Verlag Chemie, 1984: 315–23.
7. J Dermatol 1980; 7: 165–9.
< H, Koizumi H, Kimura T, Miura Y. Adenosine deaminase activity in peripheral lymphocytes of psoriasis and Sézary’s syndrome. https://doi.org/10.1111/j.1346-8138.1980.tb03528.x>
8. Respir Med 2002; 96:536–41.
< O, Karnak D, Delibalta M, Beder S, Karaca L, Tutkak H. Adenosine deaminase activity in bronchoalveolar lavage in Turkish patients with smear negative pulmonary tuberculosis. https://doi.org/10.1053/rmed.2001.1284>
9. Arch Dermatol Res 1983; 275:340–4.
< H, iizuka H, Aoyagi T, Miura Y. Adenosine deaminase in human epidermis from healthy and psoriatic subjects. https://doi.org/10.1007/BF00417203>
10. Acta Derm Venereol (Stockh) 1992; 72:410–12.
H, Ohkawara A. Adenosine deaminase activity in sera of patients with psoriasis, mycosis fungoides and adult T cell leukemia.
11. Br J Dermatol 2001; 144:1121–6.
< K, Utas S, Yazici C, Akdas A, Kelestimur F. Effect of propylthiouracil on adenosine deaminase activity and thyroid function in patients with psoriasis. https://doi.org/10.1046/j.1365-2133.2001.04221.x>
12. Arch Dermatol 1989; 125:235–40.
< R, Barton SP, Shuttleworth D, Finlay AY. Assessment of disease progress in psoriasis. https://doi.org/10.1001/archderm.1989.01670140087017>
13. Acta Derm Venereol. 1995; 75:297–9.
P, Filipe P, Emerit i, Freitas J, Guerra Rodrigo F, Manso C. Adenosine deaminase in progressive systemic sclerosis.
14. J Clin Lab immunol 1984; 14: 103–5.
S, Russo M, Pizzella T, Galanti B. Selectively increased adenosine deaminase levels in T cells during typhoid fever.
15. J Am Acad Dermatol 1992; 27:411–4.
< T, Nakajima H. Serum adenosine deaminase activity in systemic sclerosis (scleroderma) and related disorders. https://doi.org/10.1016/0190-9622(92)70209-X>
16. J Lab Clin Med 1996; 127:348–52.
< T, Hasegawa Y, Saito H, Yamori S, Shimokata K. Adenosine deaminase isozymes in tuberculous pleural effusion. https://doi.org/10.1016/S0022-2143(96)90182-1>
17. Cancer Res 1981; 41:3107–10.
H, Stanton A, Davis BH. Adenosine deaminase activity in lymphoid subpopulations and leukemias.
18. Klin Lab Diagn 1998; 3:3–6.
Yu V, Markusheva Li, Toguzov RT. Metabolism of purine compounds in psoriasis.
19. Bratisl Lek Listy 1995; 96: 137–40.
F, Mikulikova D. The effect of methotrexate on activity of T-lymphocyte marker enzymes in patients with psoriasis vulgaris.
20. Arch Dermatol 1982; 118:869–74.
JJ. Commentary: cyclic adenosine monophosphate regulation of normal and psoriatic epidermis.